- New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical Conversations
- OptimizeRx Reports First Quarter 2024 Financial Results
- OptimizeRx to Participate in Upcoming Investor Conferences
- OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET
- OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
- OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results
- OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row
- OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET
- OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
- OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort
More ▼
Key statistics
On Wednesday, OPTIMIZERx Corp (OPRX:NAQ) closed at 10.00, 44.51% above the 52 week low of 6.92 set on Oct 09, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 10.09 |
---|---|
High | 10.15 |
Low | 9.94 |
Bid | 10.00 |
Offer | 11.08 |
Previous close | 10.07 |
Average volume | 130.50k |
---|---|
Shares outstanding | 18.27m |
Free float | 15.87m |
P/E (TTM) | -- |
Market cap | 182.70m USD |
EPS (TTM) | -1.03 USD |
Data delayed at least 15 minutes, as of Jul 03 2024 18:00 BST.
More ▼